March 3, 2017 Conference

  


TEST
Title
Dry Age-related Macular Degeneration: AREDS and Beyond

Return to Session

Author
Mr. Deeba Husain, Massachusetts Eye and Ear Infirmary (Presenter)
Speaker Session Topic
Abstract
Age related macular degeneration is the leading cause of blindness in the developed world and third leading cause worldwide. About 196 million are projected to have AMD globally by 2020 and 288 million by 2040. We do not completely understand the pathobiology of AMD. Therefore at this time there are no FDA approved treatments for dry AMD and there a great unmet need to find treatments for dry AMD. There is a lot of ongoing research in this area . In this talk I will talk about our current knowledge based on clinical trials such as AREDS study, on diagnosis, prognosis, monitoring of disease and role of vitamins. I will also talk about some of newer agents that are in clinical trials at this time including drugs that block the complement pathways, Neuroprotective agents, statins, and cell therapies.
Video